Clinical trial
Multi-center, Randomized,Placebo and Positive Controlled Clinical Study of TPN171H Tablets on Acute Haemodynamics in Patients with Pulmonary Arterial Hypertension
NCT04483115 is registered in ClinicalTrials.gov with Vigonvita Life Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-center, Randomized,Placebo and Positive Controlled Clinical Study of TPN171H Tablets on Acute Haemodynamics in Patients with Pulmonary Arterial Hypertension
- Lead sponsor
- Vigonvita Life Sciences
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 16, 2020
- Completion date
- June 29, 2022
- Enrollment
- 60 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.